Download PDF
Semin Neurol 2016; 36(02): 185-195
DOI: 10.1055/s-0036-1579692
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Vision Disturbances in Multiple Sclerosis

Fiona Costello
1   Department of Clinical Neurosciences, University of Calgary, Hotchkiss Brain Institute, Foothills Medical Centre, MS Clinic, Clinical Neurosciences, Calgary, Alberta
2   Department of Surgery, University of Calgary, Hotchkiss Brain Institute, Foothills Medical Centre, MS Clinic, Clinical Neurosciences, Calgary, Alberta
› Author Affiliations
Further Information

Publication History

Publication Date:
26 April 2016 (online)

    Permissions and Reprints

Abstract

Visual disturbances are frequently encountered in multiple sclerosis (MS), and include problems with how affected individuals see the world (afferent visual pathway symptoms) and how their eyes move together (efferent visual pathway disorders). Optic neuritis is the most common afferent visual pathway manifestation of MS, from which visual recovery is often incomplete. Visual field defects caused by lesions in the retrochiasmal or retrogeniculate regions of the afferent visual pathway also occur, albeit less frequently. Efferent visual pathway lesions causing ocular misalignment and nystagmus may lead to diplopia and oscillopsia, respectively. Vision loss has a major impact on perceptions regarding quality of life in MS. Therefore, it is important for clinicians to be able to identify and localize the underlying basis of visual disturbances to provide the best care possible for their patients.

Keywords

multiple sclerosis - optic neuritis - diplopia - nystagmus - oscillopsia
 

  • References

  • 1 Costello F. The afferent visual pathway: designing a structural-functional paradigm of multiple sclerosis. ISRN Neurol 2013; 2013: 134858
    PubMedGoogle Scholar
  • 2 Balcer LJ, Miller DH, Reingold SC, Cohen JA. Vision and vision-related outcome measures in multiple sclerosis. Brain 2015; 138 (Pt 1) 11-27
    CrossrefPubMedGoogle Scholar
  • 3 Compston A, Coles A. Multiple sclerosis. Lancet 2008; 372 (9648) 1502-1517
    CrossrefPubMedGoogle Scholar
  • 4 Costello FE, Lee AG, Burton JM. Neuro-ophthalmic manifestations of multiple sclerosis. Available at: http://emedicine.medscape.com/article/1214270-overview . Accessed January 22, 2015
    PubMedGoogle Scholar
  • 5 Miller D, Barkhof F, Montalban X, Thompson A, Filippi M. Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol 2005; 4 (5) 281-288
    CrossrefPubMedGoogle Scholar
  • 6 Costello F, Burton JM. An approach to optic neuritis: the initial presentation. Expert Rev Ophthalmol 2013; 8 (6) 539-551
    CrossrefPubMedGoogle Scholar
  • 7 Beck RW, Cleary PA, Anderson Jr MM , et al; The Optic Neuritis Study Group. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N Engl J Med 1992; 326 (9) 581-588
    CrossrefPubMedGoogle Scholar
  • 8 Beck RW. Optic neuritis. In: Miller NR, Newman NJ, , eds. Walsh & Hoyt's Clinical Neuro-Ophthalmology. Vol, 5. 5th ed. Baltimore, MD: Williams & Wilkins; 1999: 599-647
    Google Scholar
  • 9 Wilejto M, Shroff M, Buncic JR, Kennedy J, Goia C, Banwell B. The clinical features, MRI findings, and outcome of optic neuritis in children. Neurology 2006; 67 (2) 258-262
    CrossrefPubMedGoogle Scholar
  • 10 Keltner JL, Johnson CA, Cello KE, Dontchev M, Gal RL, Beck RW ; Optic Neuritis Study Group. Visual field profile of optic neuritis: a final follow-up report from the optic neuritis treatment trial from baseline through 15 years. Arch Ophthalmol 2010; 128 (3) 330-337
    CrossrefPubMedGoogle Scholar
  • 11 Hickman SJ, Dalton CM, Miller DH, Plant GT. Management of acute optic neuritis. Lancet 2002; 360 (9349) 1953-1962
    CrossrefPubMedGoogle Scholar
  • 12 Costello F. Inflammatory optic neuropathies. Continuum (Minneap Minn) 2014; 20 (4 Neuro-ophthalmology): 816-837 (Minneap Minn)
    PubMedGoogle Scholar
  • 13 Shams PN, Plant GT. Optic neuritis: a review. Int MS J 2009; 16 (3) 82-89
    PubMedGoogle Scholar
  • 14 Polman CH, Reingold SC, Banwell B , et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69 (2) 292-302
    CrossrefPubMedGoogle Scholar
  • 15 Modvig S, Degn M, Horwitz H , et al. Relationship between cerebrospinal fluid biomarkers for inflammation, demyelination and neurodegeneration in acute optic neuritis. PLoS ONE 2013; 8 (10) e77163
    CrossrefPubMedGoogle Scholar
  • 16 Heussinger N, Kontopantelis E, Gburek-Augustat J , et al; for GRACE-MS (German-speaking Research Alliance for ChildrEn with Multiple Sclerosis). Oligoclonal bands predict multiple sclerosis in children with optic neuritis. Ann Neurol 2015; 77 (6) 1076-1082
    CrossrefPubMedGoogle Scholar
  • 17 Balcer LJ. Clinical practice. Optic neuritis. N Engl J Med 2006; 354 (12) 1273-1280
    CrossrefPubMedGoogle Scholar
  • 18 van der Walt A, Kolbe S, Mitchell P , et al. Parallel changes in structural and functional measures of optic nerve myelination after optic neuritis. PLoS ONE 2015; 10 (5) e0121084
    CrossrefPubMedGoogle Scholar
  • 19 Sriram P, Wang C, Yiannikas C , et al. Relationship between optical coherence tomography and electrophysiology of the visual pathway in non-optic neuritis eyes of multiple sclerosis patients. PLoS ONE 2014; 9 (8) e102546
    CrossrefPubMedGoogle Scholar
  • 20 Syc SB, Saidha S, Newsome SD , et al. Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain 2012; 135 (Pt 2) 521-533
    CrossrefPubMedGoogle Scholar
  • 21 Costello F, Pan YI, Yeh EA, Hodge W, Burton JM, Kardon R. The temporal evolution of structural and functional measures after acute optic neuritis. J Neurol Neurosurg Psychiatry 2015; 86 (12) 1369-1373
    CrossrefPubMedGoogle Scholar
  • 22 Gabilondo I, Martínez-Lapiscina EH, Fraga-Pumar E , et al. Dynamics of retinal injury after acute optic neuritis. Ann Neurol 2015; 77 (3) 517-528
    CrossrefPubMedGoogle Scholar
  • 23 Petzold A, de Boer JF, Schippling S , et al. Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol 2010; 9 (9) 921-932
    CrossrefPubMedGoogle Scholar
  • 24 Fisher JB, Jacobs DA, Markowitz CE , et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology 2006; 113 (2) 324-332
    CrossrefPubMedGoogle Scholar
  • 25 Kupersmith MJ, Gal RL, Beck RW, Xing D, Miller N ; Optic Neuritis Study Group. Visual function at baseline and 1 month in acute optic neuritis: predictors of visual outcome. Neurology 2007; 69 (6) 508-514
    CrossrefPubMedGoogle Scholar
  • 26 Raz N, Dotan S, Benoliel T, Chokron S, Ben-Hur T, Levin N. Sustained motion perception deficit following optic neuritis: behavioral and cortical evidence. Neurology 2011; 76 (24) 2103-2111
    CrossrefPubMedGoogle Scholar
  • 27 The Optic Neuritis Study Group. Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. Arch Neurol 2008; 65 (6) 727-732
    PubMedGoogle Scholar
  • 28 Martinelli V, Rocca MA, Annovazzi P , et al. A short-term randomized MRI study of high-dose oral vs intravenous methylprednisolone in MS. Neurology 2009; 73 (22) 1842-1848
    CrossrefPubMedGoogle Scholar
  • 29 Burton JM, O'Connor PW, Hohol M, Beyene J. Oral versus intravenous steroids for treatment of relapses in multiple sclerosis. Cochrane Database Syst Rev 2009; 8 (3) CD006921
    PubMedGoogle Scholar
  • 30 Raz N, Chokron S, Ben-Hur T, Levin N. Temporal reorganization to overcome monocular demyelination. Neurology 2013; 81 (8) 702-709
    CrossrefPubMedGoogle Scholar
  • 31 Pineles SL, Birch EE, Talman LS , et al. One eye or two: a comparison of binocular and monocular low-contrast acuity testing in multiple sclerosis. Am J Ophthalmol 2011; 152 (1) 133-140
    CrossrefPubMedGoogle Scholar
  • 32 Saidha S, Sotirchos ES, Ibrahim MA , et al. Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study. Lancet Neurol 2012; 11 (11) 963-972
    CrossrefPubMedGoogle Scholar
  • 33 Gelfand JM, Nolan R, Schwartz DM, Graves J, Green AJ. Microcystic macular oedema in multiple sclerosis is associated with disease severity. Brain 2012; 135 (Pt 6) 1786-1793
    CrossrefPubMedGoogle Scholar
  • 34 Saidha S, Syc SB, Ibrahim MA , et al. Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain 2011; 134 (Pt 2) 518-533
    CrossrefPubMedGoogle Scholar
  • 35 Kaya D, Kaya M, Özakbaş S, İdiman E. Uveitis associated with multiple sclerosis: complications and visual prognosis. Int J Ophthalmol 2014; 7 (6) 1010-1013
    PubMedGoogle Scholar
  • 36 Gordon LK, Goldstein DA. Gender and uveitis in patients with multiple sclerosis. J Ophthalmol 2014; 2014: 565262
    PubMedGoogle Scholar
  • 37 McClelland C, Galetta S. Eye symptoms, signs, and therapy in multiple sclerosis. In: Rae-Grant A, Fox R, Bethoux F, , eds. Multiple Sclerosis and Related Disorders: Diagnosis, Medical Management, and Rehabilitation. New York: Demos Medical Publishing; 2013: 179-86
    Google Scholar
  • 38 Walsh RD, McClelland CM, Galetta SL. The neuro-ophthalmology of multiple sclerosis. Future Neurol 2012; 7 (6) 679-700
    CrossrefPubMedGoogle Scholar
  • 39 Jain N, Bhatti MT. Fingolimod-associated macular edema: incidence, detection, and management. Neurology 2012; 78 (9) 672-680
    CrossrefPubMedGoogle Scholar
  • 40 Bermel RA, Villoslada P. Retrograde trans-synaptic degeneration in MS: a missing link?. Neurology 2014; 82 (24) 2152-2153
    CrossrefPubMedGoogle Scholar
  • 41 Sørensen PS, Bertolotto A, Edan G , et al. Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab. Mult Scler 2012; 18 (2) 143-152
    CrossrefPubMedGoogle Scholar
  • 42 Prasad S, Galetta SL. Eye movement abnormalities in multiple sclerosis. Neurol Clin 2010; 28 (3) 641-655
    CrossrefPubMedGoogle Scholar
  • 43 Frohman TC, Galetta S, Fox R , et al. Pearls & Oy-sters: the medial longitudinal fasciculus in ocular motor physiology. Neurology 2008; 70 (17) e57-e67
    CrossrefPubMedGoogle Scholar
  • 44 Wong AM. Understanding skew deviation and a new clinical test to differentiate it from trochlear nerve palsy. J AAPOS 2010; 14 (1) 61-67
    CrossrefPubMedGoogle Scholar
  • 45 Straube A, Bronstein A, Straumann D. Nystagmus and oscillopsia. In: Gilhus NE, Barnes MP, Brain M, , eds. European Handbook of Neurological Management. Vol. 1. 2nd ed. Oxford: Blackwell Publishing Ltd; 2011: 484-492
    CrossrefGoogle Scholar